People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s ...
Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss ...
Eli Lilly (LLY) stock is rising after the company said its weight-loss drug achieved better results than Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback